{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T13:27:14Z","timestamp":1780493234338,"version":"3.54.1"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.cca.2017.12.045","type":"journal-article","created":{"date-parts":[[2017,12,29]],"date-time":"2017-12-29T03:26:24Z","timestamp":1514517984000},"page":"152-156","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Presepsin as a novel diagnostic biomarker for differentiating active pulmonary tuberculosis from bacterial community acquired pneumonia"],"prefix":"10.1016","volume":"478","author":[{"given":"Zhi-jiang","family":"Qi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0997-5296","authenticated-orcid":false,"given":"Chun-sheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 6","key":"10.1016\/j.cca.2017.12.045_bb0005","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1111\/j.1469-0691.2011.03672.x","article-title":"Guidelines for the management of adult lower respiratory tract infections\u2013full version","volume":"17","author":"Woodhead","year":"2011","journal-title":"Clin. Microbiol. Infect."},{"issue":"Suppl. 2","key":"10.1016\/j.cca.2017.12.045_bb0010","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1086\/511159","article-title":"Infectious Diseases Society of America\/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults","volume":"44","author":"Mandell","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.cca.2017.12.045_bb0015","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.medmal.2011.07.012","article-title":"Diagnosis of pulmonary tuberculosis in a microbiological laboratory","volume":"41","author":"El Kh\u00e9chine","year":"2011","journal-title":"Med. Mal. Infect."},{"key":"10.1016\/j.cca.2017.12.045_bb0020","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1128\/JCM.02451-10","article-title":"Role of the clinical mycobacteriology laboratory in diagnosis and management of tuberculosis in low-prevalence settings","volume":"49","author":"Parrish","year":"2011","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.cca.2017.12.045_bb0025","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.cca.2015.06.026","article-title":"Presepsin (sCD14-ST), an innate immune response marker in sepsis","volume":"450","author":"Chenevier-Gobeaux","year":"2015","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.cca.2017.12.045_bb0030","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13613-016-0160-6","article-title":"Diagnostic and prognostic value of soluble CD14 subtype (Presepsin) for sepsis and community-acquired pneumonia in ICU patients","volume":"6","author":"Klouche","year":"2016","journal-title":"Ann. Intensive Care"},{"key":"10.1016\/j.cca.2017.12.045_bb0035","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.rmed.2014.05.005","article-title":"Role of Presepsin (sCD14-ST) and the CURB65 scoring system in predicting severity and outcome of community-acquired pneumonia in an emergency department","volume":"108","author":"Liu","year":"2014","journal-title":"Respir. Med."},{"key":"10.1016\/j.cca.2017.12.045_bb0040","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13613-016-0160-6","article-title":"Diagnostic and prognostic value of soluble CD14 subtype (Presepsin) for sepsis and community-acquiredpneumonia in ICU patients","volume":"6","author":"Klouche","year":"2016","journal-title":"Ann. Intensive Care"},{"key":"10.1016\/j.cca.2017.12.045_bb0045","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s00134-014-3514-2","article-title":"Circulating presepsin (soluble CD14 subtype) as a marker of host response in patients with severe sepsis or septic shock: data from the multicenter, randomized ALBIOS trial","volume":"41","author":"Masson","year":"2015","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.cca.2017.12.045_bb0050","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.amjms.2017.03.036","article-title":"Soluble CD14 subtype-a new biomarker in predicting the outcome of critically ill septic patients","volume":"353","author":"Matera","year":"2017","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.cca.2017.12.045_bb0055","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3389\/fcimb.2013.00032","article-title":"Role of CD14 in host protection against infections and in metabolism regulation","volume":"3","author":"Zanoni","year":"2013","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.cca.2017.12.045_bb0060","article-title":"WHO publishes Global tuberculosis report 2013","volume":"18","author":"Eurosurveillance editorial team","year":"2013","journal-title":"Euro. Surveill."},{"key":"10.1016\/j.cca.2017.12.045_bb0065","article-title":"Diagnosis and treatment of community-acquired pneumonia in adults: 2016 clinical practice guidelines by the Chinese Thoracic Society, Chinese Medical Association","author":"Cao","year":"2017","journal-title":"Clin. Respir. J."},{"key":"10.1016\/j.cca.2017.12.045_bb0070","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1111\/acem.12929","article-title":"CURB-65 performance among admitted and discharged emergency department patients with community-acquired pneumonia","volume":"23","author":"Sharp","year":"2016","journal-title":"Acad. Emerg. Med."},{"key":"10.1016\/j.cca.2017.12.045_bb0075","doi-asserted-by":"crossref","first-page":"747543","DOI":"10.1155\/2015\/747543","article-title":"Innate immune defenses in human tuberculosis: an overview of the interactions between Mycobacterium tuberculosis and innate immune cells","volume":"2015","author":"Sia","year":"2015","journal-title":"J Immunol Res"},{"key":"10.1016\/j.cca.2017.12.045_bb0080","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s10156-005-0400-4","article-title":"Evaluation of a newly identified soluble CD14 subtype as a marker for sepsis","volume":"11","author":"Yaegashi","year":"2005","journal-title":"J. Infect. Chemother."},{"key":"10.1016\/j.cca.2017.12.045_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0069896","article-title":"Soluble markers of the toll-like receptor 4 pathway differentiate between active and latent tuberculosis and are associated with treatment responses","volume":"8","author":"Feruglio","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.cca.2017.12.045_bb0090","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.5588\/ijtld.11.0827","article-title":"Association between the CD14 gene C-159T polymorphism and serum soluble CD14 with pulmonary tuberculosis","volume":"16","author":"Alavi-Naini","year":"2012","journal-title":"Int. J. Tuberc. Lung Dis."},{"key":"10.1016\/j.cca.2017.12.045_bb0095","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1086\/314492","article-title":"Serum concentrations of lipopolysaccharide activity-modulating proteins during tuberculosis","volume":"178","author":"Juffermans","year":"1998","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.cca.2017.12.045_bb0100","doi-asserted-by":"crossref","DOI":"10.1111\/acem.13255","article-title":"Bacteremia prediction model for community-acquired pneumonia: external validation in a multicenter retrospective cohort","author":"Kim","year":"2017","journal-title":"Acad. Emerg. Med."},{"key":"10.1016\/j.cca.2017.12.045_bb0105","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/jhm.382","article-title":"Blood cultures for community-acquired pneumonia: are they worthy of two quality measures? A systematic review","volume":"4","author":"Afshar","year":"2009","journal-title":"J. Hosp. Med."},{"key":"10.1016\/j.cca.2017.12.045_bb0110","first-page":"83","article-title":"A prospective study of the diagnostic utility of sputum Gram stain in pneumonia","volume":"59","author":"Anevlavis","year":"2009","journal-title":"J. Inf. Secur."},{"key":"10.1016\/j.cca.2017.12.045_bb0115","first-page":"534","article-title":"Validation of sputum Gram stain for treatment of community-acquired pneumonia and healthcare-associated pneumonia: a prospective observational study, BMC","volume":"14","author":"Fukuyama","year":"2014","journal-title":"Infect. Dis."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898117305466?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898117305466?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,7,9]],"date-time":"2018-07-09T06:29:32Z","timestamp":1531117772000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898117305466"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":23,"alternative-id":["S0009898117305466"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2017.12.045","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Presepsin as a novel diagnostic biomarker for differentiating active pulmonary tuberculosis from bacterial community acquired pneumonia","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2017.12.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}